EUVIMEDEUVIMED entdecken
Crossref

Antibiotic Profile of Pseudomonas aeruginosa in a Tertiary Care Hospital

Sandeep Kumar Singh, Kalapana Sadawarte

International Journal of Current Pharmaceutical Review and Research · 31.03.2026 · 18 (03)

DOI: 10.25258/ijcpr.18.3.174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 31.03.2026. Verfasst von Sandeep Kumar Singh und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pseudomonas aeruginosa is an important opportunistic pathogen responsible for both hospital-acquired and community-acquired infections. Its intrinsic and acquired resistance to multiple antibiotics poses significant therapeutic challenges. This study aimed to evaluate the prevalence and antibiogram of P. aeruginosa isolates in a tertiary care hospital. A total of 503 clinical samples were processed, out of which 32 isolates of P. aeruginosa were identified, giving a prevalence rate of 6.38%. Antibiotic susceptibility testing revealed variable resistance patterns, with all isolates remaining sensitive to colistin. A considerable proportion (27%) of isolates were multidrug-resistant. Continuous surveillance and rational antibiotic use are essential to control infections caused by this organism.

Zitieren

APA

Singh, S. K., & Sadawarte, K. (2026). Antibiotic Profile of Pseudomonas aeruginosa in a Tertiary Care Hospital. International Journal of Current Pharmaceutical Review and Research, 18(03). https://doi.org/10.25258/ijcpr.18.3.174

Vancouver

Singh SK, Sadawarte K. Antibiotic Profile of Pseudomonas aeruginosa in a Tertiary Care Hospital. International Journal of Current Pharmaceutical Review and Research. 2026;18(03). doi:10.25258/ijcpr.18.3.174

BibTeX
@article{Singh2026,
  author = {Singh, Sandeep Kumar and Sadawarte, Kalapana},
  title = {Antibiotic Profile of Pseudomonas aeruginosa in a Tertiary Care Hospital},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {03},
  doi = {10.25258/ijcpr.18.3.174}
}
Kostenlos starten →